# DoH and Sanofi Partner to Advance Vaccine Innovation

- Link: https://www.thailand-business-news.com/pr-news/doh-and-sanofi-partner-to-advance-vaccine-innovation
- Published: 2026-06-23T06:47:00+07:00
- Author: PR Newswire

|   |

ABU DHABI, UAE, June 23, 2026 /PRNewswire/ — The Department of Health – Abu Dhabi(
DoH), the regulator of the healthcare sector in Abu Dhabi, and Sanofi, a worldwide
biopharma and vaccines leader, have signed an Memorandum of Understanding and intend
to into an agreement to advance their partnership in vaccine innovation and to jointly
explore the development of a Vaccine Innovation Centre in Abu Dhabi. The collaboration
would strengthen capabilities across AI-enabled vaccine discovery, mRNA research,
clinical development and manufacturing, and support regional and global preparedness
for future public health challenges.

 [⌊In the presence of H.E. Dr.Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi and Danilo Casimiro, Chief Scientific Officer and Head of External Scientific Affairs Vaccines at Sanofi, Dr. Mohamed Al Ameri, Division Director of Genome and Biobank at DoH and Laurie Gery, Global Head of Business Development Vaccines at Sanofi signed the MoU during BIO International Convention 2026 in San Diego, USA⌉](https://mma.prnasia.com/media2/2998667/The_Department_of_Health_Abu_Dhabi.jpg?p=medium600)

In the presence of H.E. Dr.Noura Al Ghaithi, Undersecretary of the Department of
Health – Abu Dhabi and Danilo Casimiro, Chief Scientific Officer and Head of External
Scientific Affairs Vaccines at Sanofi, Dr. Mohamed Al Ameri, Division Director of
Genome and Biobank at DoH and Laurie Gery, Global Head of Business Development Vaccines
at Sanofi signed the MoU during BIO International Convention 2026 in San Diego, 
USA

Operating within Abu Dhabi’s Health, Endurance, Longevity, and Medicine (HELM) Cluster,
the collaboration intends to bring together scientific research, clinical infrastructure,
academic expertise, enabling regulation and advanced manufacturing within a single
ecosystem.

**H.E. Dr. Noura Al Ghaithi, Undersecretary of the DoH**, said: "Through our partnership
with Sanofi, we are bringing together AI, scientific research, clinical expertise,
advanced manufacturing and enabling regulation within a single ecosystem designed
to accelerate the journey from discovery to impact. This partnership reflects Abu
Dhabi’s commitment to creating an environment where innovators can build, test and
scale solutions that improve lives, strengthen preparedness and advance health outcomes
for communities around the world."

**Baptiste de Clarens, General Manager Vaccines, Greater Gulf at Sanofi, said:**"
We are proud to deepen our collaboration with the DoH. Vaccine innovation today 
is being reshaped by artificial intelligence, by advances in mRNA science, and by
new models that connect discovery, development and manufacturing. We look forward
to exploring how these capabilities can be brought together to accelerate the journey
from discovery to the patients."

The planned Vaccine Innovation Centre is expected to strengthen Abu Dhabi’s contribution
to global health security while supporting the development of local scientific talent,
advanced manufacturing capabilities and next-generation vaccine innovation. Through
the advancement of vaccine research, development and manufacturing capabilities 
in the region, the centre will help expand access to advanced vaccines and strengthen
preparedness for future public health challenges.

The announcement forms part of Abu Dhabi’s participation at BIO International Convention
2026, where the emirate is showcasing its intelligent life sciences ecosystem and
partnerships across genomics, gene editing, AI-enabled health innovation, advanced
therapeutics and rare disease.

A key enabler of the emirates intelligent life sciences ecosystem is Abu Dhabi’s
Health, Endurance, Longevity and Medicine (HELM) Cluster, which connects research,
investment, commercialisation and healthcare implementation within a single ecosystem.

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [DoH and Sanofi Partner to Advance Vaccine Innovation ](http://www.prnasia.com/story/archive/4989652_AE89652_0?rand=184833)